Edition:
India

Aclaris Therapeutics Inc (ACRS.OQ)

ACRS.OQ on NASDAQ Stock Exchange Global Select Market

20.10USD
17 Jul 2018
Change (% chg)

$-0.40 (-1.95%)
Prev Close
$20.50
Open
$20.67
Day's High
$20.80
Day's Low
$19.95
Volume
62,466
Avg. Vol
97,547
52-wk High
$30.06
52-wk Low
$16.24

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.12 -0.979
FY 2017 Dec '17 1.00 -0.802
Sep '17 0.68 -0.631
Jun '17 0.00 -0.558
Mar '17 0.00 -0.482
FY 2016 Dec '16 0.00 -0.491
Sep '16 0.00 -0.499
Jun '16 0.00 -0.623
Mar '16 0.00 -0.646
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 5 4.55 5.50 3.80 --
Quarter Ending Dec-18 5 8.99 10.70 6.70 --
Year Ending Dec-18 5 16.69 18.53 14.30 30.12
Year Ending Dec-19 6 70.59 94.13 54.30 132.85
Earnings (per share)
Quarter Ending Sep-18 3 -1.15 -1.05 -1.23 --
Quarter Ending Dec-18 3 -1.18 -1.15 -1.22 --
Year Ending Dec-18 4 -4.15 -3.39 -4.68 -3.21
Year Ending Dec-19 6 -3.25 -2.14 -4.10 -0.53
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -95.66 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aclaris Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 0.58 -2.89 99 --
13 Week -1.71 -6.50 99 --
26 Week -14.92 -21.38 99 --
52 Week 12.14 -4.95 99 --
YTD 1.73 -10.66 99 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 145
Total Shares Held: 31,443,088
3 Mo. Net Change: 610,442
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 9
# Reduced Positions: 3
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.